A comparison of intravenous prostaglandin E2 and intravenous oxytocin for the augmentation of labour complicated by delay.
D000328:Adult; D002585:Cesarean Section; D005260:Female; D005334:Fever / Q000139:chemically induced; D005865:Gestational Age; D006801:Humans; D007275:Injections, Intravenous; D007662:Ketosis / Q000139:chemically induced; D007751:Labor, Induced; D009325:Nausea / Q000139:chemically induced; D007744:Obstetric Labor Complications / Q000188:drug therapy*; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010298:Parity; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013223:Statistics as Topic; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins; D010121:Oxytocin